Chapter 14 Vascular Malformations (Arteriovenous Malformations and Dural Arteriovenous Fistulas)
• Arteriovenous malformations (AVMs) are congenital, high-flow, high-pressure lesions with the primary risk of devastating intracerebral hemorrhage.
• Important characteristics of any AVM include nidus size and location, number and locations of arterial feeders, and pattern of venous drainage.
• Only complete removal of the arteriovenous shunt has been shown to definitively reduce the risk of bleeding.
• Treatment modalities include surgical resection, radiosurgery, endovascular occlusion, or some combination of these approaches.
• Dural arteriovenous fistulas are a subset of AVMs that are thought to be acquired rather than congenital. Treatment focuses on the control of cortical venous drainage to reduce hemorrhage risk.
Classification and Definitions
First, a vascular malformation of the central nervous system is believed to be a dysplastic process, which should be distinguished from a neoplastic process (i.e., a hemangioma is defined as a neoplasm derived from the endothelial cells of a blood vessel). Some literature will, for example, refer to a cavernous malformation as a “cavernoma” or “cavernous angioma,” with the suffix “oma” implying a neoplastic process. In a similar manner, one may also encounter the name “venous angioma” used to describe a developmental venous anomaly. In the category of dysplastic vascular malformations, there have traditionally been four pathological entities:1–3 developmental venous anomalies, capillary telangiectasias, cavernous malformations, and AVMs. In addition, mixed malformations have been found, though they are thought to be rare.4 What separates an AVM from the first three is the presence of an arteriovenous shunt, which is defined as oxygenated blood passing directly into the venous system without gas exchange occurring in a capillary bed. These shunts are characterized by high flow and high pressure, which distinguish them from other vascular malformations.
AVMs may be plexiform, fistulous, or both. A fistulous malformation may be an otherwise normal artery directly joining a vein. A plexiform malformation is defined as an artery connecting to a network of poorly differentiated, immature vessels before passing into a vein. This plexiform network can be termed a nidus (Latin term for “nest”). Figure 14.1 shows a plexiform nidus on the cortical surface. AVMs with plexiform and fistulous components can be seen in any intracranial structure. Because of their developmental nature, they can span multiple structures that are otherwise anatomically distinct. Because they can occur anywhere in the brain, the term brain AVM (BAVM) is coming into wider use and becoming more accepted.5 However, one may encounter multiple adjectives that attempt to describe the malformation (true, cerebral, pial, parenchymal, cisternal, ventricular, medullary) but do not necessarily imply a separate type of pathological entity. However, there is one exception: Dural AVFs (dAVFs) are a distinct pathological type in that their development is not thought to be strictly congenital but acquired. The dAVF will be treated as a separate pathological entity and will be discussed later.
Diagnostic Radiology
Cross-Sectional Imaging
A noncontrast head computed tomography (CT) scan is useful in the acute determination of intracranial hemorrhage. Because this is usually the first study acquired in patients with AVMs, it is important to recognize key features that could arouse suspicion of an AVM. First is that 25% to 30% of AVMs have calcium deposition6 that may be apparent even in the presence of a mass-displacing hemorrhage. In addition, there may be evidence of iso- to hyperdense serpiginous vessels that might be located at some distance from the hemorrhage. Noncontrast CT has no role in ruling out an AVM because many cannot be visualized. A CT angiogram (CTA) may be helpful in an unruptured AVM to help delineate the nidus and associated vessels.
A weakness common to both CT and MR modalities is the lack of temporal sequencing of images to determine the dynamic aspect of the malformation. A good example of this for the MRA (or CTA) is that when all vessels are uniformly enhanced in any image one cannot distinguish between a nidus feeding artery or a draining vein without supplemental anatomical information which may be distorted in a malformation.
Angiography
No cerebral arteriovenous shunt can be completely understood without the aid of a selective cerebral angiogram. In fact, the history of the understanding of this pathology was dependent on the technological developments in the field of radiology. The modern equivalent is the digital subtraction angiogram (DSA), which can subtract out static components of the image (i.e., the skull) to allow the viewer a better visualization of the dynamic components. The main weakness of the angiography when compared to cross-sectional imaging is the lack of good geometric characterization and localization of the nidus. This is more evident as the size of the malformations increases. However, the primary utility of DSA is to establish the diagnosis of an arteriovenous shunt by locating early opacification of the nidus or draining veins in the routine arterial phase of the angiogram (Table 14.1).7 The characterization of this shunting helps to determine not only the pathophysiology of a particular case but also provides a common communication platform upon which various treatment modalities can be discussed between specialists.
Radiological Findings
A judicious use of diagnostic imaging studies is warranted with these complex lesions. A Joint Writing Group publication, in 2001, was a multidisciplinary effort to provide guidelines in the standardized reporting of AVMs for the purposes of clinical research.5 A summary of the important features is provided here. However, note that when AVMs are described, certain characteristics may have more clinical relevance.
Nidus
The size of an AVM usually refers to that of the nidus itself, though the presence of adjacent dilated veins may be confounding. Generally, cross-sectional imaging will provide a more accurate assessment using the same measurement techniques as those for any intracranial mass lesion. Location of the nidus is a second characteristic to note. One is particularly concerned about its proximity to eloquent brain structures.8 Both size and location, though better characterized on cross-sectional imaging, can be roughly estimated as well on angiography, as shown in Figure 14.2A. Additionally, one should characterize the shape for surgical or radiosurgical planning. Unusual geometries may be obscured in angiograms. In locating the nidus, the first step in microsurgical treatment would be consideration of the needed approach for any mass lesion in that location and the potential morbidity.
Arterial Supply
Arteries supplying the AVM should be noted for number, size, relative contribution to the nidus, and location. They can be characterized first by noting what vascular territory they arise from. Angiography from each intracranial vessel should be performed. The detailed description of the intracerebral anatomical vasculature is beyond the scope of this chapter. However, when describing the source of a feeding vessel it would be best to describe its course from the circle of Willis. For large AVMs, when there is concern for meningeal involvement, angiograms of the external carotid arteries should be done as well. Contribution from deep perforating arteries should be clearly noted as they are particularly difficult to deal with in surgery. Finally, one should note that large AVMs or even smaller ones in the temporal or occipital lobe may lie in the vascular border zone between the anterior and posterior circulations; they could, therefore, have vascular pedicles from both. In the era before digitized images, one could simply overlay the transparent films from multiple angiographic injections to get an idea of the complete nidus along with relative locations of erratic feeders. Modern, electronic PACS (picture archiving and communication system) software does not yet seem to have a simple equivalent (Fig. 14.2B).
There are three types of arterial feeders. Direct feeders are the simplest to conceptualize: they end directly and exclusively in the nidus, and they are also known as terminal feeders. Transit arteries are normal arteries that appear on angiogram to pass near or even through the nidus while going on to supply normal tissue. These normal arteries can be easily obscured during nidus opacification. At the same time, their distal territory may never get a sufficient supply of contrast to opacify. An example may be the pericallosal artery passing adjacent to a mesial frontal lobe nidus before proceeding posteriorly. The third type of feeding artery is the indirect feeder or artery en passage. This artery combines the previous two in that as it passes near the nidus it can contribute to the shunt before continuing on to supply normal brain. AVMs within the sylvian fissure usually harbor many en passage contributions from the distal middle cerebral arteries. Rotational angiography and three-dimensional reconstruction has now replaced the old-fashioned stereoangiography, which previously provided excellent tracking of the course of feeding arteries and draining veins.
One other point of importance is the supply to AVM coming from pial collaterals. An AVM in the parietal area, for example, may have most of its supply from the middle cerebral artery, but it also gets its contribution from the posterior cerebral branches coursing over the hemisphere essentially supplying the distal territory of middle cerebral artery beyond the AVM (Fig. 14.2C). Even though these vessels are larger than normal, they are not suitable for endovascular occlusion. This fact also needs to be taken into consideration during microsurgery so that the supply to the normal brain is not affected.
Venous Drainage
The draining veins may be of unusual caliber with a tortuous course, ectasias, or stenosis.9 Of particular importance to note is whether the veins drain superficially via the cortical surface or deeply to the vein of Galen. This is usually easy to identify with an angiogram as the first evidence of an arteriovenous shunt is early opacification of the veins by using anatomical recognition of the vein of Galen along with the major cerebral venous sinuses.
Special Tests
Use of adjunctive diagnostic studies is helpful in selective cases. Functional MRI (fMRI) has helped assess the proximity of language and motor function in relation to AVM but has limitations (Fig. 14.3). Magnetic source imaging (MSI) can accurately localize sensory cortex and even visual and motor areas and the information can be overlaid on the MRI. Recently introduced, tractography should aid in assessing the relationship of deep white matter tracts to the AVM. The information derived from these studies is helpful in deciding the treatment and possibly assessing the neurological risk before intervention. Intraoperative functional mapping has limited value because one cannot do partial treatment in AVMs, in contrast to tumors.
Grading Systems
Clinicians have been attempting to classify AVMs with the goal of helping patients understand the risks by comparison to historical outcomes. An ideal classification system would have the flexibility to cover many pathological variants, the simplicity to be used in a bedside fashion, and the utility to prognosticate. The variability and rarity of AVMs, however, have made this goal difficult to achieve in practice. Several classification schemes have been proposed.10,11 Of these, the Spetzler-Martin system (Table 14.2)12 has the most widespread use and should be known by the practicing neurosurgeon. Grades I and II AVM patients generally tolerated resection without morbidity while grade IV and V AVMs had higher risks of postoperative deficits. Retrospective and prospective studies have shown its utility for surgical decision making.12,13 There are several weaknesses of this system, however. First, it lacks the ability to assess risks for interventions other than exclusive microneurosurgery. Second, the studies were carried out by a highly experienced vascular team and may not necessarily be applicable to a general neurosurgeon’s ability. Third, despite its simplicity, interobserver variability can still occur.14 Finally, there is continuing concern that this system may oversimplify many AVMs. A more recent classification scheme attempts to add deep perforator supply and nidus diffuseness parameters to the Spetzler-Martin system15 as predictors of higher surgical morbidity rates. The chief drawback is the difficultly applying the diffuseness parameter based on imaging (Fig. 14.4). These factors, however, have been recognized to make microsurgical resection more challenging.
Lesion Characteristic | Points Assigned |
---|---|
Size | |
Small: diameter <3 cm | 1 |
Medium: diameter 3-6 cm | 2 |
Large: diameter >6 cm | 3 |
Location | |
Noneloquent site | 0 |
Eloquent site (sensorimotor, language, or visual cortex; hypothalamus or thalamus; internal capsule; brainstem; cerebellar peduncles; or cerebellar nuclei) | 1 |
Pattern of venous drainage | |
Superficial only | 0 |
Any deep | 1 |
∗Total scores range from 0 to 5; high scores are associated with high risk of permanent neurological deficit after surgery.
FIGURE 14.4 Axial magnetic resonance imaging (MRI) with gadolinium shows a large left frontal lobe nidus with a high level of diffuseness compared to the one seen in Figure 14.1. This characteristic, though not part of the Spetzler-Martin scale, may increase treatment morbidity.
(From Du R, Keyoung HM, Dowd CF, et al. The effects of diffuseness and deep perforating artery supply on outcomes after microsurgical resection of brain arteriovenous malformations. Neurosurgery 2007;60(4):638-646; discussion 646-648.)
In most of the grading schemes the size measurement is taken as a linear parameter, which when taken in the context of volume, has tremendous variation within the range of dimension. As an example, the spherical volume of a 5.54-cm-diameter AVM is approximately four times greater than an AVM measuring 3.5 cm, even though both of them are assigned 2 points in the Spetzler-Martin scale. Treatment with radiosurgery is volume dependent. In addition, several series have shown that volume is a better predictor of microsurgical risk and outcomes. The approximate volume can be determined by the formula: (length × width × height)/2. These measurements can be obtained from the anteroposterior (AP) and lateral views of the angiogram corrected for magnification.
Pathological Sequelae
Seizures
Seizures are the second most common presenting symptom; they are associated with supratentorial AVMs. Approximately 15% to 30% of all patients with AVMs present with a focal or generalized seizure.16–18 Angiographic characteristics of epileptogenic AVMs include cortical location of the nidus or feeding artery, feeding by the middle cerebral artery, absence of aneurysms, presence of varices in the venous drainage, and association of varix and absence of intranidal aneurysms. Other factors significantly associated with the onset of seizures include AVMs fed by the external carotid artery and a temporal or parietal cortical location.19
An AVM patient presenting with epilepsy has a similar long-term risk profile for hemorrhage when compared to other presentations. That said, some patients may not wish to consider definitive treatment for reasons of age, comorbid conditions, or personal preference. Medical control of seizures with antiepileptic drugs (AEDs) is the first-line treatment. Consultation with neurological epileptologists for multidrug therapy is also indicated. There may, however, be a subset of patients harboring AVMs with medically refractory seizures. Neurological consultation can confirm location of the epileptic focus using clinical semiology or tools such as electroencephalography (EEG), magnetoencephalography (MEG), or single-photon emission computed tomography (SPECT). Given that most AVMs do not harbor functional tissue, the location of this epileptic focus with respect to the actual AVM nidus may help decide the best course of treatment, which may include radiosurgery.20,21
Headaches
Headaches are the presenting symptom in approximately 15% of patients without evidence of rupture.16 They can be characterized as similar to migraines with lateralization to one side, but they may have a more permanent nature. This fact does not necessarily preclude migraines as an independent pathological entity, however, and patients should be informed that the goal of a successful AVM treatment is obliteration of the nidus in order to mitigate risk of debilitating hemorrhage. Occipital AVMs may be a predisposing factor.
Neurological Deficit
A relatively rare presentation for an unruptured AVM is neurological deficit. Deficits may present as transient, progressive, or permanent and the spectrum of deficits varies with the morphological nature of the malformation. Deficits can arise through a number of mechanisms. First, the AVM itself may cause mass effect on adjacent neurovascular structures. Another possibility may be mass effect caused by arterial steal. The arteriovenous shunting may be disruptive to the vascular supply and regulation of surrounding normal brain structures by redirecting flow toward the shunt at a cost to normal vascular beds. This concept, if true, suggests that large AVMs with high flow should correlate with increased physiological evidence of steal. In fact, steal is thought to be relatively rare because the surrounding tissue does manage to adapt.22,23
Development
There has been much speculation about how arteriovenous malformations are thought to develop. Traditionally it has been thought that they are congenital lesions that develop during the embryonic stage. This reasoning stems from histological examination of AVM structures that reveal characteristics that resemble the plexuses of developing vasculature in the embryo. There is also predisposition to develop AVMs in patients with genetic disorders such as Osler-Weber-Rendu and Wyburg-Mason syndromes.24
Against this theory, however, is the fact that AVMs have been known to recur after post-treatment angiographic evidence of obliteration by surgery or radiosurgery, although recurrence is very rare.25 One must keep in consideration that the imaging resolution limit of an angiogram prohibits adequate visualization of the microcirculation. With this in mind, the question becomes whether these postnatal malformations arise de novo or develop into larger structures that can eventually be seen radiographically. In either case, the evidence supports the theory that AVMs are not static lesions but biologically dynamic and that they can develop and remodel over time.
The congenital theory of AVM development suggests that there is a failure of the development of a stable vascular and capillary plexus.26 During embryological development of the nervous system, neuronal growth and migration help shape the vascular network that eventually will supply it. As an example, the population of neurons that develop in the germinal matrix near the ventricle and migrate radially outward toward the cortex can have vessels growing in tandem or, more commonly, migrating from the cortex inward in an antiparallel fashion.
Vascular development is believed to be a concerted mechanism that is a successive combination of three processes: vasculogenesis, angiogenesis, and arteriogenesis (Table 14.3).26,27 Vasculogenesis is thought to occur exclusively in the embryonic period. It is defined as a process of differentiation of vascular progenitor cells into angioblastic cells which eventually form the endothelial layer of all vessels. The vasculogenesis process creates a haphazard network of immature cells that form angiocysts, which eventually fuse to form a primitive capillary plexus. The next process, angiogenesis, involves selective apoptosis along with the migration of supporting vascular smooth muscle cells to form a stable vascular bed. The interplay of these two processes during the embryonic stage requires multiple steps for cell proliferation, migration, differentiation, and programmed destruction. Any misstep during this stage could be the initiating factor in the formation of a congenital vascular malformation.
Molecular Biology and Genetics
The study of the molecular changes with AVMs has revealed the altered expression of many factors that are known to have key roles in the developmental processes noted previously. What is more interesting is that many are shared with cerebral neoplastic processes as well. This suggests that there may be a future role for targeted medical therapies based on the understanding of the abnormal molecular pathways initiated and sustained by these active lesions. Around 900 genes have been shown to have altered expression in AVMs.26,28 Detailing the molecular factors implicated in the embryological development of cerebral vessels is beyond the scope of this chapter. However, a few of those factors that have abnormally high expression in AVMs when compared to normal brain tissue have been noted here.26
The congenital theory of development can imply that an AVM begins as a response to some environmental abnormality during development or that a genetic alteration was initially responsible. In the case of the latter, genetic alterations may be sporadic or familial. Several genetic disease syndromes have been associated with an increased predisposition to harbor AVMs such as Wyburn-Mason syndrome, Sturge-Weber disease, and ataxia-telangiectasia.24,26
Osler-Weber-Rendu disease, also known as hereditary hemorrhagic telangiectasia, is an autosomal dominant disorder with variable penetrance. Genetic analysis has isolated two sources for mutation: HHT1 is found on chromosome 9q and HHT2 is found on chromosome 12q. Incidence for AVM in HHT1 mutations is approximately 10 times higher than that for HHT2, which shows that different genetic mutations alter the risk of developing AVMs based on the function each encoded protein has during development.29 In addition to known hereditary disorders, there have been AVM cases among families, suggesting a multifactorial genetic patterning to formation.
Physiology
The hemodynamics of AVMs is a subject of continuing study. It is difficult to model an AVM using fluid dynamic models given their individual variability. Some electrical network analogies have been described in the literature in order to help conceptualize individual elements within a complex system.30,31 For the scope of this chapter, it may be simpler to reduce the concept into flow rates and pressures through three structures—the feeding artery, the nidus, and the draining vein—of an AVM with one of each. In this model, for conservation of mass, any flow increase to one structure will be the same to all. Flow increase may be achieved, however, through increased feeding arterial pressure, decreased draining pressure, or decrease in the vascular resistance of the AVM by enlargement of the nidus. A nidus can enlarge by increasing the diameter of existing vessels or generating new ones. Note that if a nidus increase can bring about decreased vascular resistance, the feeding artery’s pressure can either drop or its flow rate can increase until a new equilibrium is reached. For pressure to increase in a nidus, flow can be increased by increasing pressure in the feeding artery or flow can be decreased by increasing pressure (indirectly by increasing distal resistance) in the draining vein. This model neglects the fact that many AVMs are not so simple. Also, there is the possibility of capacitance, that is, the ability of the nidus to increase flow without necessarily increasing vascular resistance or, therefore, pressure.
With these concepts in mind, some general hemodynamic considerations in AVM therapies are as follows: (1) Decreasing flow is best effected by obstructing feeding arteries, and (2) decreasing flow by obstructing veins will increase intranidal pressures and, therefore, bleeding risk (Fig. 14.5).